These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19760045)
1. RGS16 is a marker for prognosis in colorectal cancer. Miyoshi N; Ishii H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2009 Dec; 16(12):3507-14. PubMed ID: 19760045 [TBL] [Abstract][Full Text] [Related]
2. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients. Tunca B; Tezcan G; Cecener G; Egeli U; Zorluoglu A; Yilmazlar T; Ak S; Yerci O; Ozturk E; Umut G; Evrensel T J Cancer Res Clin Oncol; 2013 Apr; 139(4):691-702. PubMed ID: 23322277 [TBL] [Abstract][Full Text] [Related]
4. High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients. Lee HY; Ahn JB; Rha SY; Chung HC; Park KH; Kim TS; Kim NK; Shin SJ World J Surg Oncol; 2014 Jul; 12():232. PubMed ID: 25060774 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer. Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188 [TBL] [Abstract][Full Text] [Related]
6. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer. Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer. Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475 [TBL] [Abstract][Full Text] [Related]
8. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1. Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689 [TBL] [Abstract][Full Text] [Related]
9. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454 [TBL] [Abstract][Full Text] [Related]
11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
12. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma. Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. Wang L; Shi S; Guo Z; Zhang X; Han S; Yang A; Wen W; Zhu Q PLoS One; 2013; 8(6):e65539. PubMed ID: 23762387 [TBL] [Abstract][Full Text] [Related]
14. Kinesin 18A expression: clinical relevance to colorectal cancer progression. Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216 [TBL] [Abstract][Full Text] [Related]
15. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status. Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042 [TBL] [Abstract][Full Text] [Related]
16. RHBDD2: a 5-fluorouracil responsive gene overexpressed in the advanced stages of colorectal cancer. Lacunza E; Canzoneri R; Rabassa ME; Zwenger A; Segal-Eiras A; Croce MV; Abba MC Tumour Biol; 2012 Dec; 33(6):2393-9. PubMed ID: 22965880 [TBL] [Abstract][Full Text] [Related]
17. Expression and significance of the Wip1 proto-oncogene in colorectal cancer. Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302 [TBL] [Abstract][Full Text] [Related]
19. The significance of PITX2 overexpression in human colorectal cancer. Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692 [TBL] [Abstract][Full Text] [Related]
20. Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma. Wang Y; Hua L; Lu C; Chen Z World J Surg Oncol; 2011 Dec; 9():166. PubMed ID: 22166120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]